UBS Keeps Their Buy Rating on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276)

In a report released on July 2, from UBS maintained a Buy rating on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H, with a price target of H...

Raccontata damarkets.businessinsider.com